Brief: Reneo Pharmaceuticals Inc Announces Notice Of Allowance For Patent Application On REN001
14/10/2021 13:03
Oct 14 (Reuters) - Reneo Pharmaceuticals Inc RPHM.O :
* RENEO PHARMACEUTICALS ANNOUNCES NOTICE OF ALLOWANCE FOR
PATENT
APPLICATION ON REN001
* RENEO PHARMACEUTICALS INC - COMPOSITION OF MATTER PATENT
APPLICATION COVERS REN001 DRUG SUBSTANCE
* RENEO PHARMACEUTICALS INC - PATENT APPLICATION IS EXPECTED
TO
ISSUE AS A PATENT AT EARLIEST IN 2021
Source text for Eikon: ID:nGNX5L6JW2
Further company coverage: RPHM.O
Recent news on Onkure Therapeutics
See all newsBrief: Onkure Therapeutics Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Onkure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Onkure Therapeutics Inc expected to post a loss of $1.46 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-F5, Nextracker, Stryker